• Profile

The combination of CYP3A4*22 and CYP3A5*3 single-nucleotide polymorphisms determines tacrolimus dose requirement after kidney transplantation

Pharmacogenetics and genomics Aug 15, 2017

Lloberasm N, et al. – The physicians examined the associations of single–nucleotide polymorphisms (SNPs) in drug–metabolizing enzymes (CYP3A) with tacrolimus (Tac) pharmacokinetics in renal transplant recipients. They observed a major influence of the combined CYP3A4 and CYP3A5 genotype of renal transplant recipients on the Tac dose required to reach the target exposure.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen